Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 0.14 | 11.72 | 0.24 | 1.25 |
Short Term Investments | 1.50 | - | - | - |
Cashand Short Term Investments | 1.64 | 11.72 | 0.24 | 1.25 |
Accounts Receivable- Trade Net | 122.55 | 81.51 | 73.48 | 60.39 |
Total Receivables Net | 122.55 | 81.51 | 73.48 | 60.39 |
Total Inventory | 85.74 | 74.57 | 46.87 | 23.96 |
Other Current Assets Total | 31.64 | 30.83 | 9.00 | 2.03 |
Total Current Assets | 241.57 | 198.62 | 129.58 | 87.64 |
Property/ Plant/ Equipment Total- Net | 22.41 | 19.00 | 6.88 | 5.98 |
Goodwill Net | 4.36 | - | - | - |
Intangibles Net | 0.62 | 0.90 | 0.12 | 0.23 |
Long Term Investments | 12.34 | 12.34 | 0.00 | 0.00 |
Note Receivable- Long Term | 1.83 | 1.62 | 0.94 | 5.40 |
Total Assets | 283.13 | 232.48 | 137.52 | 99.26 |
Accounts Payable | 56.72 | 91.89 | 73.75 | 44.22 |
Notes Payable/ Short Term Debt | 94.35 | 21.32 | 22.12 | 21.38 |
Other Currentliabilities Total | 9.76 | 5.27 | 5.17 | 5.62 |
Total Current Liabilities | 160.82 | 118.48 | 101.04 | 71.22 |
Long Term Debt | 10.49 | 12.79 | 6.52 | 5.32 |
Total Long Term Debt | 10.49 | 12.79 | 6.52 | 5.32 |
Total Debt | 104.84 | 34.10 | 28.64 | 26.70 |
Deferred Income Tax | 0.02 | 0.18 | 0.14 | 0.14 |
Other Liabilities Total | 0.09 | 0.06 | 0.04 | 0.03 |
Total Liabilities | 171.42 | 131.50 | 107.75 | 76.75 |
Common Stock Total | 24.07 | 24.07 | 9.75 | 9.55 |
Retained Earnings( Accumulated Deficit) | 87.64 | 76.91 | 20.03 | 12.96 |
Total Equity | 111.71 | 100.97 | 29.78 | 22.51 |
Total Liabilities Shareholders' Equity | 283.13 | 232.48 | 137.52 | 99.26 |
Total Common Shares Outstanding | 2.41 | 2.41 | 0.97 | 0.97 |
Tangible Book Valueper Share Common Eq | 44.35 | 41.58 | 30.42 | 22.85 |
Property/ Plant/ Equipment Total- Gross | - | 21.16 | - | - |
Accumulated Depreciation Total | - | -2.17 | - | - |
Other Long Term Assets Total | - | 0.00 | - | 0.00 |
Minority Interest | - | - | 0.00 | 0.05 |
Other Equity Total | - | - | - | 0.00 |
Sudarshan Pharma Industries Dividend Sudarshan Pharma Industries Bonus Sudarshan Pharma Industries News Sudarshan Pharma Industries AGM Sudarshan Pharma Industries Rights Sudarshan Pharma Industries Splits Sudarshan Pharma Industries Board Meetings Sudarshan Pharma Industries Key Metrics Sudarshan Pharma Industries Shareholdings Sudarshan Pharma Industries Profit Loss Sudarshan Pharma Industries Cashflow Sudarshan Pharma Industries Q1 Results Sudarshan Pharma Industries Q2 Results Sudarshan Pharma Industries Q3 Results Sudarshan Pharma Industries Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks